Latest news
PDS Biotech Announces Strategic Refocus Prioritizing PDS0301 in Metastatic Colorectal Cancer (mCRC) and Partnership Strategy for PDS0101 - The Manila TimesThe Manila Times · Tue, 11 Aug 2026 12:40:31 GMTPDS0301 Data Show 80% 24-Month Survival With Liver Metastases - Stock TitanStock Titan · Tue, 11 Aug 2026 12:25:00 GMT